このコンテンツを視聴するには最新バージョンの Adobe Flash Player を利用していることが必要です。
- : 2016-07-20
- Evec has started offering several contract services.
- : 2014-07-17
- Our anti-MPV Abs, EV046120 and EV046135, have high neutralization activities not only for MPV but also for RSV.
- : 2014-06-20
- Monoclonal Abs that we have generated are those for Cytomegalovirus, Clostridium difficile, RS virus, human Metapneumovirus (hMPV) and high mobility group box 1 (HMGB1). We are seeking for pharmaceutical companies who could develop these Abs toward pharmaceuticals. Please contact email@example.com.
please click here
- : 2011-09-05
- Evec signed the contract with Astellas Pharma Inc. , licensing one antibody for commercial development.
Astellas Pharma Inc.
- : 2010-01-22
- Kenzo Takada, MD, PhD received the Hokkaido Science and Technology Award.
- : 2008-09-30
- Evec signed the contract with Boehringer Ingelheim GmbH (Germany), licensing one kind of antibody for commercial development.